Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05601869 · ClinicalTrials.gov registry record · NA

Impact of Improving Footwear Options

A NA study of Amputation, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT05601869: Recruiting NA study of Amputation, sponsored by VA Office of Research and Development.

NCT05601869 is a NA study of Amputation that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 18 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05601869, a NA study of Amputation, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Veterans with leg amputations have limited footwear options because their artificial feet do not change shapes for different shoes. Studies have shown that women with amputations receive more frequent prosthetics care than men, but are less satisfied with the fit, comfort, and appearance of their prostheses. The investigators' previous research indicates that women Veterans would like to be able to wear a broader variety of footwear, and those who perceive more footwear limitations tend to have poorer body image and community participation. A new prosthesis designed by the investigators' group allows Veterans with amputations to use their footwear of choice using 3D-printed artificial feet with a single ankle. The novel prosthesis will be tested in this project with women Veterans with amputations to determine the impact of improving footwear options on body image and community participation.

Primary Outcome

The ABIS-R is a 14-item scale that assesses body image disturbance among individuals with amputations. Responses are reported on a 1 to 3 scale, with higher values representing greater body image disturbance.

Conditions Studied

Interventions

  • DEVICE RECOVER Prosthetic Ankle-Feet System

Study Locations (1)

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2023-09-01
Est. Completion 2026-03-31
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT05601869 shows while recruiting

NCT05601869 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which RECOVER Prosthetic Ankle-Feet System is the first listed.

NCT05601869 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05601869 about?

NCT05601869 is a clinical study titled "Impact of Improving Footwear Options". Veterans with leg amputations have limited footwear options because their artificial feet do not change shapes for different shoes. Studies have shown that women with amputations receive more frequent prosthetics care than men, but are less satisfied with the fit, comfort, and appearance of their pr...

What is the current status of trial NCT05601869?

This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2023-09-01. Estimated completion is 2026-03-31.

What conditions does trial NCT05601869 study?

This clinical trial studies the following conditions: Amputation.

What interventions are being tested in trial NCT05601869?

The interventions under investigation include: RECOVER Prosthetic Ankle-Feet System (DEVICE).

Who is sponsoring clinical trial NCT05601869?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05601869 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05601869's enrollment target sits among peer trials

18 42nd of 65 higher than 24 of 65 other Amputation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05601869, the US trial registry maintained by the National Library of Medicine. NCT05601869 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.